Studies: HD-PEI vs. PEB in poor prognosis patients

ID Trial

EORTC 30974

Clinicaltrials.gov identifier

NCT00003941

Description

A randomized phase III study of sequential high-dose Cisplatinum/Etoposide/Ifosfamide plus stem cell support versus BEP in patients with poor prognosis Germ Cell Cancer

Status

closed

Stages

Stage  
metastatic poor prognosis

Treatment arms

Name Description  
A 1x PEI und 3x HD-PEI
B 4x PEB

Trial characteristics

No data

Disease characteristics

No data

Treatment characteristics

No data

Patient characteristics

Age between 16 and 50 years
ECOG ≤ 3

Hematology

Thrombocytes ≥ 100.000/µl

Liver functon

Bilirubin bis 1,25x normal
Transaminasen bis 2x normal

Coordinating investigator

Prof. Dr. C. Bokemeyer
Universitätsklinikum Hamburg-Eppendorf
II. Medizinische Klinik und Poliklinik
Martinistr. 52
20246 Hamburg
 Prof. Dr. H. Schmoll
Universitätsklinikum der Martin Luther Universität Halle Wittenberg
Universitätsklinik und -poliklinik für Innere Medizin IV
Ernst-Grube-Str. 40
06120 Halle

Principal investigator

No data